PD-1 expression on natural killer cells and CD8+ T cells during chronic HIV-1 infection

Viral Immunology

Volumn 25, Issue 4, 2012, Pages 329-332

  Norris, Sonia ^a   Coleman, Adam ^a   Kuri Cervantes, Leticia ^a   Bower, Mark ^a   Nelson, Mark ^a   Goodier, Martin R ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; PROGRAMMED DEATH 1 RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE CULTURE; NATURAL KILLER CELL; PROTEIN EXPRESSION;

CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84864999052     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0096     Document Type: Article

References (15)

1. Alvarez IB, Pasquinelli V, Jurado JO, Abbate E, Musella RM, De La Barrera SS, and Garcia VE: Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 2010;202:524-532.
2. Day CL, Kaufmann DE, Kiepiela P, et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-354.
3. Fauci AS, Mavilio D, and Kottilil S: NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat Rev Immunol 2005;5:835-843.
4. Fogli M, Costa P, Murdaca G, et al.: Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 2004;34:2313-2321.
5. Freeman GJ, Wherry EJ, Ahmed R, and Sharpe AH: Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006;203:2223-2227.
6. Golden-Mason L, Klarquist J, Wahed AS, and Rosen HR: Cutting edge: Programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: Race-dependent differences. J Immunol 2008;180:3637-3641.
7. Grabmeier-Pfistershammer K, Steinberger P, Rieger A, Leitner J, and Kohrgruber N: Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment. J Acquir Immune Defic Syndr 2011;56:118-124.
8. Gregson JN, Steel A, Bower M, Gazzard BG, Gotch FM, and Goodier MR: Elevated plasma lipopolysaccharide is not sufficient to drive natural killer cell activation in HIV-1-infected individuals. AIDS 2009;23:29-34.
9. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, and Fauci AS: The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008;181: 6738-6746.
10. Mavilio D, Lombardo G, Kinter A, et al.: Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006;203:2339-2350.
11. Mela CM, Steel A, Lindsay J, Gazzard BG, Gotch FM, and Goodier MR: Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals. AIDS 2007;21:2177-2182.
12. Petrovas C, Casazza JP, Brenchley JM, et al.: PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006;203:2281-2292.
13. Petrovas C, Chaon B, Ambrozak DR, et al.: Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 2009;183:1120-1132.
14. Petrovas C, Price DA, Mattapallil J, et al.: SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 2007;110:928-936.
15. Trautmann L, Janbazian L, Chomont N, et al.: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.